Allergan Inc (NYSE:AGN) Sentiment Crashed to 0.5, Because

June 27, 2018 - By Joshua Cleveland

Allergan plc (NYSE:AGN) Corporate Logo

Allergan Inc’s Sentiment

“Big money sentiment for Allergan Inc (NYSE:AGN) in 2018 Q1 decreased to 0.5, according to filings. So its down -0.75, from 2017Q4’s 1.25. 2 investment managers increased or started new positions, while 4 sold and reduced their positions in Allergan Inc so the sentiment has dropped. These funds own 77,429 shares, that’s up from 44,210 shares in 2017Q4. Funds holding Allergan Inc in top 10 was flat from 0 to 0 for the same number . In total 1 funds closed positions, 3 reduced and 2 increased. Also 0 funds bought new Allergan Inc stakes.

Significant Allergan Inc Investors

Grassi Investment Management owns 42,335 shares in Allergan Inc as of 2018 Q1. Allergan Inc’s shareholder Callahan Advisors Llc owns 15,273 shares as of 2018 Q1. Mitchell Mcleod Pugh & Williams Inc reported 3,965 shares. The Massachusetts-based fund Cubic Asset Management Llc have invested about 0.1% of the investment manager’s stock portfolio in Allergan Inc. The California-based fund Gemmer Asset Management Llc looks positive on Allergan Inc, having 101 shares.

Allergan plc, a specialty pharmaceutical company, develops, makes, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide.The company has $57.40 billion market cap. It operates through US Specialized Therapeutics, US General Medicine, and International divisions.Last it reported negative earnings. The firm offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, womenÂ’s health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as AlzheimerÂ’s disease.

Ticker’s shares touched $169.29 during the last trading session after 0.36% change.Currently Allergan plc is downtrending after 31.36% change in last June 27, 2017. AGN has also 55,184 shares volume. The stock underperformed the S&P500 by 43.93%.

Allergan plc (NYSE:AGN) is expected to announce earnings on August, 2., as reported by RTT. EPS of $4.13 is 2.74 % up from 2017’s $4.02 EPS. If $4.13 is reported, AGN’s profit will reach $1.40B for 10.25 P/E. Analysts at Wall Street see Allergan plc’s 10.43 % EPS growth compared to $3.74 EPS for last quarter.

Rech Management holds 0% of its capital in Allergan plc (NYSE:AGN) for 33 shs. Gemmer Asset Ltd Co invested in 101 shs or 0.01% of the stock. Mitchell Mcleod Pugh Williams Inc, a Alabama-based fund reported 3,965 shs. Cubic Asset Mngmt stated it has 2,130 shs or 0.1% of all its holdings. 15,273 were reported by Callahan Advisors Limited Company. Grassi holds 42,335 shs. Frontier invested in 13,592 shs.

Allergan plc (NYSE:AGN) Ratings Coverage

Total analysts of 16 have positions in Allergan (NYSE:AGN) as follows: 11 rated it a “Buy”, 0 with “Sell” and 5 with “Hold”. The positive are 69%. The firm has $25500 highest while $15000 is the lowest PT. The average target $207.73 is 22.71% above the last ($169.29) price. Since January 3, 2018 according to StockzIntelligence Inc Allergan has 27 analyst reports. On Thursday, January 4 RBC Capital Markets maintained the shares of AGN in report with “Buy” rating. On Thursday, March 1 Credit Suisse maintained Allergan plc (NYSE:AGN) rating. Credit Suisse has “Buy” rating and $215.0 target. On Wednesday, January 10 the stock has “Buy” rating by UBS. The stock rating was maintained by Cowen & Co with “Buy” on Monday, April 16. On Tuesday, April 24 the stock has “Buy” rating by Citigroup. On Wednesday, February 7 the firm earned “Buy” rating by Bank of America. The company rating was maintained by Morgan Stanley on Thursday, March 1. In Wednesday, January 17 report Susquehanna maintained the stock with “Hold” rating. On Tuesday, February 6 the company was maintained by Piper Jaffray. On Wednesday, February 7 the company was maintained by Leerink Swann.

For more Allergan plc (NYSE:AGN) news published recently go to:,,, or The titles are as follows: “Bernstein: What Activism Means For Allergan Shareholders” published on June 08, 2018, “The ‘Joe Papa’ Effect Is Arriving At Valeant” on June 11, 2018, “Allergan: Unwelcome Guests?” with a publish date: June 08, 2018, “Allergan Needs Earnings To Be Sustained” and the last “Advancing Neurostimulation Therapies for Optical Deficiencies Impacting Healthcare Industry in a Billion Dollar Way” with publication date: June 27, 2018.

Allergan plc (NYSE:AGN) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.